Investigational treatment is being evaluated in patients with C3 glomerulopathy More: Novartis’ iptacopan hits endpoints in mid-stage study Source: News
read moreForxiga becomes the first new treatment option for CKD patients in nearly 20 years More: NICE issues draft recommendation for new kidney disease treatment Source: News
read moreSurprise COVID-19 antibody sales of $804M help Regeneron trounce expectations in third quarter kdunleavy Thu, 11/04/2021 – 11:06 More: Surprise COVID-19 antibody sales of 4M help Regeneron trounce expectations in third quarter Source: fierce
read moreMerck and Ridgeback’s COVID-19 oral antiviral molnupiravir joins the pandemic response with U.K. nod esagonowsky Thu, 11/04/2021 – 10:58 More: Merck and Ridgeback's COVID-19 oral antiviral molnupiravir joins the pandemic response with U.K. nod Source: fierce
read moreNovartis exits 20-year Roche stake, creating a $20.7B question about CEO Vas Narasimhan’s next M&A move aliu Thu, 11/04/2021 – 10:34 More: Novartis exits 20-year Roche stake, creating a .7B question about CEO Vas Narasimhan's next M&A move Source: fierce
read moreShipping delays, supply chain expansions ding Moderna’s COVID-19 vaccine business esagonowsky Thu, 11/04/2021 – 09:42 More: Shipping delays, supply chain expansions ding Moderna's COVID-19 vaccine business Source: fierce
read more© 1994 - 2026 B.M. Pharmaceuticals